Mirabegron is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2-amino-1,3-thiazol-4-ylacetic acid with the anilino group of (1R)-2-{[2-(4-aminophenyl)ethyl]amino}-1-phenylethanol. Used for the treatment of overactive bladder syndrome. Among its listed roles, it functions as a beta-adrenergic agonist. It belongs to the class of 1,3-thiazoles, an aromatic amide, a member of ethanolamines and a monocarboxylic acid amide. It is grouped under the following drug class(es): Overactive bladder agents. Its therapeutic use is listed as urological agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Myrbetriq, Betanis, Betmiga and mirabegronum. Its PubChem CID is 9865528.
Mirabegron
| CAS No | 223673-61-8 |
|---|---|
| Molecular Formula | C21H24N4O2S |
| Molecular Weight | 396.50 g/mol |
| Synonyms | 2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mirabegron is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2-amino-1,3-thiazol-4-ylacetic acid with the anilino group of (1R)-2-{[2-(4-aminophenyl)ethyl]amino}-1-phenylethanol.
The listed CAS number is 223673-61-8.
The listed molecular formula is C21H24N4O2S.
The listed molecular weight is 396.50 g/mol.
2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide.
The source lists Myrbetriq, Betanis, Betmiga and mirabegronum.